[Smoking, vaping among hospital staff during the Covid-19 pandemic: Appraisal of the "tobacco-free hospital, campus" campaign in Brest]
- PMID: 35597726
- PMCID: PMC8847087
- DOI: 10.1016/j.rmr.2022.01.020
[Smoking, vaping among hospital staff during the Covid-19 pandemic: Appraisal of the "tobacco-free hospital, campus" campaign in Brest]
Abstract
Introduction: In the framework of a "tobacco-free hospital and campus" campaign, we conducted a study on the prevalence of smoking and vaping among a university hospital (CHRU) staff. The study took place in late 2020 (from 1 September to 15 December), and involved self-assessment of the impact of the covid-19 pandemic on smoking.
Material and method: A cross-sectional study was carried out using an online questionnaire, which was distributed by email and QR code posting and included socio-professional details as well as data on participants' smoking and vaping.
Results: There were 782 responses, representing a participation rate of 13.5%. The sample included 73.3% women and 22.7% men; 28.9% nurses, 24.9% medical staff, 3.6% nursing assistants and 42.6% other professional categories. The overall smoking rate was 13%. Sixty-two (7.9%) participants vaped; 37 (5%) vaped exclusively, 25 (3.2%) combined smoking and vaping. Men smoked more than women: 23.7% vs. 9.4% (P < 0.01). Medical staff smoked and vaped less than other categories; 6.2% vs 14.8% (P < 0.01) and 4.1% vs 9.1% respectively (P=0.02). Doctors were more often non-smokers: OR=2.71 (95% CI: 1.14-6.46). Among smokers, 25% said they had increased their cigarette consumption during the covid-19 pandemic, frequently as a means of combating stress or fatigue.
Conclusion: This study showed a lower smoking rate than in the literature, possibly due to the high participation of physicians. Ours were the initial estimates of vaping among hospital staff.
Introduction: Nous avons mené, dans le cadre d’une campagne "Hôpital et Campus Sans Tabac", une étude de prévalence du tabagisme et du vapotage auprès des personnels d’un CHRU.
Matériel et méthodes: Étude transversale par questionnaire en ligne, au sujet du tabagisme et du vapotage, se déroulant entre le 01/01/2020 et le 15/12/2020.
Résultats: Sept cent quatre-vingt-deux questionnaires ont pu être analysés, soit un taux de participation de 13,5 %. L’échantillon comprenait 73,3 % de femmes et 22,7 % hommes; 28,9 % d’infirmiers, 24,9 % de personnels médical, 3,6 % d’aides-soignants et 42,6 % d’autres catégories professionnelles. Le taux de tabagisme était de 13 %. Soixante-deux (7,9 %) des participants vapotaient ; 37 (5 %) vapotaient exclusivement, 25 (3,2 %) associaient tabagisme et vapotage. Les hommes fumaient plus que les femmes : 23,7 % vs 9,4 % (p < 0,01). Les personnels médicaux fumaient et vapotaient moins que les autres catégories ; respectivement 6,2 % vs 14,8 % (p < 0,01) et 4,1 % vs 9,1 % (p = 0,02). Parmi les fumeurs, 25 % déclaraient avoir augmenté leur consommation de cigarettes pendant la pandémie de covid-19, particulièrement afin de lutter contre le stress ou la fatigue.
Conclusion: Cette étude montrait une faible prévalence de tabagisme. Il s’agissait des premières estimations du vapotage parmi du personnel hospitalier.
Keywords: Hospital; Medical Staff; Médecin; Personnel hospitalier; Smoking; Tabagisme; Vaping; Vapotage.
Copyright © 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Figures
Similar articles
-
[Cigarette and e-cigarette use among a sample of French health students].Rev Mal Respir. 2021 Feb;38(2):164-170. doi: 10.1016/j.rmr.2021.01.006. Epub 2021 Feb 12. Rev Mal Respir. 2021. PMID: 33583645 French.
-
Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.Drug Alcohol Depend. 2021 Jan 1;218:108438. doi: 10.1016/j.drugalcdep.2020.108438. Epub 2020 Nov 25. Drug Alcohol Depend. 2021. PMID: 33271434 Free PMC article.
-
Trends in vaping and smoking behavior before and during the COVID-19 pandemic in Canada: Beneficial and potentially detrimental changes.Addict Behav. 2024 Feb;149:107839. doi: 10.1016/j.addbeh.2023.107839. Epub 2023 Aug 25. Addict Behav. 2024. PMID: 37839145
-
Exposure to Tobacco-Specific Nitrosamines Among People Who Vape, Smoke, or do Neither: A Systematic Review and Meta-Analysis.Nicotine Tob Res. 2024 Feb 22;26(3):257-269. doi: 10.1093/ntr/ntad156. Nicotine Tob Res. 2024. PMID: 37619211 Free PMC article.
-
[Smoking and vaping in France].Rev Mal Respir. 2018 Jun;35(6):673-685. doi: 10.1016/j.rmr.2018.01.008. Epub 2018 Jun 23. Rev Mal Respir. 2018. PMID: 29945810 Review. French.
Cited by
-
Evidence from a Smoking Management Service in a University Teaching Hospital in Dublin, Ireland monitored by repeat surveys, 1997-2022.Prev Med Rep. 2023 Sep 13;36:102415. doi: 10.1016/j.pmedr.2023.102415. eCollection 2023 Dec. Prev Med Rep. 2023. PMID: 37744740 Free PMC article.
References
-
- Coleman N.C., Burnett R.T., Higbee J.D., et al. Cancer mortality risk, fine particulate air pollution, and smoking in a large, representative cohort of US adults. Cancer Causes Control. 2020;31:767–776. - PubMed
-
- Islami F., Bandi P., Sahar L., et al. Cancer deaths attributable to cigarette smoking in 152 U.S. metropolitan or micropolitan statistical areas, 2013-2017. Cancer Causes Control. 2021;32:311–316. - PubMed
-
- Carter B.D., Abnet C.C., Feskanich D., et al. Smoking and mortality--beyond established causes. N Engl J Med. 2015;372:631–640. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical